RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2011 /PRNewswire/ -- India's premier CRO, Max Neeman, participated in the 59th annual Neurological Society of India & Congress of Neurological Surgeons (NEUROCON) held in Jaipur, India this past December. The event was a convergence of leading neuroscientists, neurosurgeons, neurologists, physicians, surgeons, biotechnologists and researchers from across the globe to discuss advances made in the area of Neurology & Neurosurgery.
Max Neeman brought together USA and India based renowned group of Neuro and Spinal surgeons from prestigious hospitals across India and USA to form an advisory committee.
The Advisory Committee is to develop strategies for clinical research across newer therapies for central nervous system disorders. Regulatory challenges and technical issues along with associated strategies of conducting the clinical trials of newer therapies in India were planned.
Max Neeman has conducted approximately 10% surgical intervention trials to date of over 230 trials awarded. As part of the Max India Group, Max Neeman collaborates with 'Max Healthcare's' top physicians and neurosurgeons across India including Neurosciences departments, and one dedicated Neurological Institute, as part of the  hospital group; Max Healthcare.
About Max Neeman International
Max Neeman International is one of the leading and largest CROs in India and the clinical research arm of healthcare conglomerate, Max India. Our specialty is that we offer services for the successful conduct of Phase I-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Managem
|SOURCE Max Neeman International|
Copyright©2010 PR Newswire.
All rights reserved